Literature DB >> 9155057

Enhancement of immunotoxin activity using chemical and biological reagents.

M Wu1.   

Abstract

One of the major discoveries of effective therapeutics is the use of targeted treatment, such as antibody-directed toxins, i.e. immunotoxins; however, this medicine delivery strategy is still at a developmental stage. A number of problems need to be resolved; one is their inefficacy when applied in vivo. Research has stimulated interest in this area through the use of chemical reagents and other moieties to increase the activity of immunotoxins. In this article, reagents that can potentiate the cytotoxicity of immunotoxins are reviewed and the mechanisms that increase activity of immunotoxins are discussed. Lysosomotropic amines, especially ammonium chloride and chloroquine, may raise the pH value of the lysosome in which the conjugates enter. Carboxylic ionophores, e.g. monensin, can influence Golgi vacuolation, which may facilitate the routing of conjugates, augmenting activity. Calcium channel antagonists may increase immunotoxin killing through morphological or other mechanisms that are not yet well understood. Viral particles and surface structure can enhance the cytotoxicity of conjugates, probably through the mechanism of disrupting endosomes. In addition, cytokines, beta-adrenergic blockers, immunosuppressive agents (cyclosporin A) and some antibiotics (daunorubicin) can be used to increase the effect of immunotoxins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155057      PMCID: PMC2228222          DOI: 10.1038/bjc.1997.228

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  45 in total

1.  Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen.

Authors:  M Wu; S L Tang; R J Zang; H Yu
Journal:  Int J Immunopharmacol       Date:  1990

2.  T-lymphocyte killing by T101-ricin A-chain immunotoxin: pH-dependent potentiation with lysosomotropic amines.

Authors:  P Casellas; S Ravel; B J Bourrié; J M Derocq; F K Jansen; G Laurent; P Gros
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

3.  Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity.

Authors:  V K Chaudhary; Y Jinno; D FitzGerald; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 12.779

4.  Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases.

Authors:  R B Cameron; J K McIntosh; S A Rosenberg
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

5.  Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin.

Authors:  S Yokota; H Hara; Y Luo; B K Seon
Journal:  Cancer Res       Date:  1990-01-01       Impact factor: 12.701

6.  Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates.

Authors:  M J Smyth; G A Pietersz; I F McKenzie
Journal:  J Natl Cancer Inst       Date:  1987-12       Impact factor: 13.506

7.  Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice.

Authors:  J A Roth; R S Ames; K Fry; H M Lee; P J Scannon
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

8.  The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins.

Authors:  Y Endo; K Mitsui; M Motizuki; K Tsurugi
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

9.  Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of action.

Authors:  T Y Basham; E R Race; M J Campbell; T R Reid; R Levy; T C Merigan
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

10.  Enhancement of the activity of immunotoxins by analogues of verapamil.

Authors:  R Pirker; D J FitzGerald; M Raschack; Z Frank; M C Willingham; I Pastan
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 13.312

View more
  2 in total

1.  Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin.

Authors:  Christopher M Pirie; David V Liu; K Dane Wittrup
Journal:  Mol Cancer Ther       Date:  2013-07-05       Impact factor: 6.261

Review 2.  Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers.

Authors:  Hendrik Fuchs; Alexander Weng; Roger Gilabert-Oriol
Journal:  Toxins (Basel)       Date:  2016-07-01       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.